Articles

Find an Article

Filter articles

Applied Filters

Showing 61 to 70 of 309 results

LSIPR 50 2018: Big changes in Brazil

Brazil03-07-2018

With his interests in IP development, biotechnology innovation policy, and R&D, Luiz Otávio Pimentel, president of Brazil’s patent office, tells LSIPR of his aims to improve the country’s IP performance.

The future of precision medicine part 1: challenges and opportunities

UK, US13-06-2018Daniel Lim

The healthcare industry and governments around the world are turning to precision medicine as an opportunity and a potential saviour. Daniel Lim of Kirkland & Ellis discusses the issues around translating the promise of precision medicine into real world clinical practice.

Protecting patients, and patents

Canada, Indonesia, Singapore04-06-2018

Drug companies can take heart from a range of best practices in the battle against counterfeit medicines, as LSIPR finds out.

Regulation and licensing: the CRISPR conundrum continues

China, EU, US04-06-2018

As innovation in the CRISPR field continues across the world, questions are being asked about the role of regulating such a powerful tool, while discussions around licensing the technology continue, as LSIPR reports.

ZFN: a rival to CRISPR

US04-06-2018

As a rival to CRISPR in the gene-editing field, zinc finger nuclease technology is making a name for itself. LSIPR hears from Sandy Macrae, CEO of Sangamo Therapeutics, one of the key players in this area.

Keeping quiet on clinical trials

Mexico03-06-2018Anna Arroyo and Fernando Granados

Pharma companies with an interest in protecting clinical trial data in Mexico should follow international developments rather than looking closer to home, say Anna Arroyo and Fernando Granados of Uhthoff Gómez Vega & Uhthoff.

Not in the right spirit

Mexico03-06-2018Daniel Sanchez and Victor Ramirez

Mexico’s guidelines on the advertising of alcoholic beverages should be reviewed by the courts because of concerns about their lawfulness, as Daniel Sanchez and Victor Ramirez of Olivares report.

Speeding up the fight against Zika

Brazil02-06-2018Ana Paula Jardim and Andréa Granthon

Brazil’s IP office now expedites patent applications directed to the Zika virus and other neglected diseases, as Ana Paula Jardim and Andréa Granthon of Luiz Leonardos report.

Medicine for the millions

Brazil01-06-2018Alice Rayol Sandes

Product development partnerships are likely to provide great opportunities for companies seeking to market biosimilar products in Brazil, where there is a huge reliance on public healthcare. Alice Rayol Sandes of Di Blasi, Parente & Associados has more.

Keeping trade fair

Mexico01-06-2018Hector Chagoya

As Mexico prepares for a presidential election in 2018, pharma IP owners are hoping that the progress made in trade negotiations is not undone. Hector Chagoya of Becerril Coca & Becerril reports.

Showing 61 to 70 of 309 results

LSIPR